JAK3/BTK-IN-4

Modify Date: 2024-01-09 11:26:14

JAK3/BTK-IN-4 structure	Common Name	JAK3/BTK-IN-4
	CAS Number	2673196-38-6	Molecular Weight	440.93
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₂₁H₂₅ClN₈O	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of JAK3/BTK-IN-4

JAK3/BTK-IN-4 is a potent inhibitor of JAK3/BTK. BTK and JAK3 are two important targets for autoimmune diseases. Simultaneous inhibition of the BTK/JAK3 signalling pathway exhibits synergistic effects. JAK3/BTK-IN-4 has the potential for the research of JAK3 kinase and/or BTK-related diseases (extracted from patent WO2021147953A1, compound 003)[1]

Name	JAK3/BTK-IN-4

Description	JAK3/BTK-IN-4 is a potent inhibitor of JAK3/BTK. BTK and JAK3 are two important targets for autoimmune diseases. Simultaneous inhibition of the BTK/JAK3 signalling pathway exhibits synergistic effects. JAK3/BTK-IN-4 has the potential for the research of JAK3 kinase and/or BTK-related diseases (extracted from patent WO2021147953A1, compound 003)[1]
Related Catalog	Signaling Pathways >> JAK/STAT Signaling >> JAK Signaling Pathways >> Epigenetics >> JAK Signaling Pathways >> Stem Cell/Wnt >> JAK Research Areas >> Inflammation/Immunology Signaling Pathways >> Protein Tyrosine Kinase/RTK >> Btk
References	[1]. Baoguo Zhang, et al. Pyrimidinopyrimidine and pentacyclic derivatives and their applications. Patent WO2021147953A1.

Molecular Formula	C₂₁H₂₅ClN₈O
Molecular Weight	440.93

JAK3/BTK-IN-4

Use of JAK3/BTK-IN-4

Names

JAK3/BTK-IN-4 Biological Activity

Chemical & Physical Properties